URINARY CONCENTRATIONS OF FOSFOMYCIN AFTER A SINGLE 3G DOSE OF FOSFOMYCIN TO ELDERLY NURSING-HOME PATIENTS

被引:12
|
作者
JANKNEGT, R
HOOYMANS, PM
FABIUS, GTJ
NOHLMANSPAULSSEN, MKE
MACHIELSEN, C
BOOGAARDVANDENBORN, J
RANG, J
SMITS, CAM
WILLEMSTHISSEN, ME
KROMMENHOEK, A
机构
[1] MAASLAND HOSP SITTARD GELEEN,DEPT MED MICROBIOL,SITTARD,NETHERLANDS
[2] NURSING HOME ST ODILIA,6164 HK GELEEN,NETHERLANDS
来源
PHARMACY WORLD & SCIENCE | 1994年 / 16卷 / 03期
关键词
AGED; CLEARANCE; RENAL; CONCENTRATION; URINE; FOSFOMYCIN; KIDNEY DISEASES; PHARMACOKINETICS;
D O I
10.1007/BF01877485
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The urinary concentrations of fosfomycin in 7 elderly patients with impaired renal function (mean creatinine clearance 40 ml/min) were studied after a single oral dose of 3 g fosfomycin as the trometamol salt. Urine samples were collected as 12 h portions for 84 h. Urinary concentrations of fosfomycin were 1,383 mg/l (range 314 to 4,200 mg/l) in the first 12 h and gradually declined to 165 mg/l (range 65 to 365 mg/l) between 36 and 48 h. 37% of the oral dose was recovered in the urine unchanged after 84 h, but a wide range (15-60%) in urinary recovery was observed. The elimination half-lives in the patients (estimated from the renal excretion profile of fosfomycin) ranged between 7 and 24 h. These data suggest that the urinary levels obtained in this patient population exceed the minimum inhibiting concentration of the usual pathogens involved in uncomplicated cystitis for at least 48 h. After 24 h the urinary concentrations of fosfomycin are higher than those reported for healthy young subjects.
引用
收藏
页码:149 / 153
页数:5
相关论文
共 18 条
  • [1] URINARY-INCONTINENCE IN ELDERLY NURSING-HOME PATIENTS
    OUSLANDER, JG
    KANE, RL
    ABRASS, IB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (10): : 1194 - 1198
  • [2] URINARY-INCONTINENCE IN ELDERLY NURSING-HOME PATIENTS
    OUSLANDER, JG
    KANE, RL
    ABRASS, IB
    CLINICAL RESEARCH, 1982, 30 (02): : A304 - A304
  • [3] Pharmacodynamic activity of fosfomycin simulating urinary concentrations achieved after a single 3-g oral dose versus Escherichia coli using an in vitro model
    Zhanel, George G.
    Parkinson, Kate
    Higgins, Sean
    Denisuik, Andrew
    Adam, Heather
    Pitout, Johann
    Noreddin, Ayman
    Karlowsky, James A.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 88 (03) : 271 - 275
  • [4] CYSTOMETRIC EVALUATION OF ELDERLY NURSING-HOME PATIENTS WITH INDWELLING URINARY CATHETERS
    STARER, P
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1992, 15 (01) : 79 - 86
  • [5] Efficacy of Single Dose of Fosfomycin Versus a Five-Day Course of Ciprofloxacin in Patients With Uncomplicated Urinary Tract Infection
    Hassan, Muhammad Mujeeb
    Malik, Moeena
    Saleem, Rabia
    Saleem, Amna
    Zohaib, Khurram
    Malik, Adnan Younas
    Javaid, Maham
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [6] Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection
    Stein, GE
    CLINICAL THERAPEUTICS, 1999, 21 (11) : 1864 - 1872
  • [7] MORBIDITY AND MORTALITY ASSOCIATED WITH INDWELLING URINARY CATHETERS IN ELDERLY PATIENTS IN A NURSING-HOME - CONFOUNDING DUE TO THE PRESENCE OF ASSOCIATED DISEASES
    KUNIN, CM
    CHIN, QF
    CHAMBERS, S
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1987, 35 (11) : 1001 - 1006
  • [8] A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections
    Ceran, Nurgul
    Mert, Duygu
    Kocdogan, Funda Yuksel
    Erdem, Ilknur
    Adalati, Riza
    Ozyurek, Seyfi
    Goktas, Pasa
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2010, 16 (06) : 424 - 430
  • [9] AN OPEN STUDY OF THE EFFICACY AND SAFETY OF SINGLE DOSE FOSFOMYCIN TROMETAMOL IN TREATMENT OF HOSPITALIZED-PATIENTS WITH URINARY-TRACT INFECTION (PILOT-STUDY)
    MACGOWAN, AP
    BAILEY, RA
    EGNER, W
    PICKEN, DM
    REEVES, DS
    INFECTION, 1990, 18 : S107 - S108
  • [10] Fosfomycin Trometamol: A Review of Its Use as a Single-Dose Oral Treatment for Patients with Acute Lower Urinary Tract Infections and Pregnant Women with Asymptomatic Bacteriuria
    Gillian M. Keating
    Drugs, 2013, 73 : 1951 - 1966